ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 25,900 | -32.9% | 0.00% | -100.0% |
| Q1 2022 | $23,000 | 0.0% | 38,600 | -10.4% | 0.00% | 0.0% |
| Q4 2021 | $23,000 | +666.7% | 43,100 | +75.9% | 0.00% | – |
| Q3 2021 | $3,000 | +200.0% | 24,500 | +17.8% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 20,800 | +1.5% | 0.00% | – |
| Q3 2020 | $2,000 | -94.4% | 20,500 | -25.7% | 0.00% | -100.0% |
| Q1 2020 | $36,000 | +140.0% | 27,600 | +33.3% | 0.00% | +100.0% |
| Q4 2019 | $15,000 | – | 20,700 | -79.3% | 0.00% | – |
| Q4 2018 | $0 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |